NVS technical analysis

NVS Technical Analysis

Analysis date

July 15, 2026

Market

NYSE (USD)

Daily cutoff

July 14, 2026

Reliability

Passed

Informational use only. This page is not investment advice.

Data verification

NVS Data Verification

Cross-validating the latest completed daily bar across independent sources.

Symbol
NVS
Market
NYSE
Currency
USD (US Dollar)
Latest completed bar
July 14, 2026

No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.

SourceLatest CloseDateDifferenceStatus
Yahoo Finance Chart API (primary)134.72July 14, 2026-Verified
Google Finance (independent)134.72July 14, 2026 (previous close)0.00%Verified

Bottom line

NVS Technical Analysis Summary

NVS shows a cautiously bullish daily trend within a strongly bullish weekly uptrend. The daily price at 134.72 holds above SMA20 (131.55) and SMA200 (121.30) but trades slightly below SMA50 (135.10), reflecting a short-term consolidation after the recent pullback from the 52-week high of 148.52. The daily RSI at 48.32 sits just below the neutral 50 level, indicating slightly bearish momentum in the near term. The daily MACD at -0.85 with a negative histogram at -0.32 signals weak short-term momentum. On the weekly chart, the trend remains clearly bullish with all SMAs in ascending order, though the weekly RSI at 52.41 has pulled back from overbought levels after the correction. Key support rests at 128.52 (20-day low) and the stronger floor at 112.49 (200-day SMA). Resistance sits at 140.13 (20-day high) and 148.52 (52-week high). A sustained move above the SMA50 at 135.10 would mark the first step toward resuming the uptrend.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (July 14, 2026)

Trend
Mixed. Price at 134.72 is above SMA20 (131.55) and SMA200 (121.30) but below SMA50 (135.10). The SMA20 at 131.55 is below the SMA50 at 135.10, indicating a short-term bearish cross within the context of a longer-term uptrend. The SMA50 at 135.10 remains well above the SMA200 at 121.30, confirming the golden cross on the daily timeframe remains intact despite the recent pullback.
Momentum
Slightly bearish. RSI14 at 48.32 is marginally below the 50 midline, indicating mild bearish momentum. MACD at -0.85 is below the zero line with the signal line at -0.53, and the histogram at -0.32 continues to print negative values, confirming that short-term downside momentum has not yet exhausted.
Volatility
Moderate. ATR14 at 4.18 (3.10% of price) reflects typical daily ranges for a large-cap pharmaceutical ADR. Bollinger Bands (123.72 to 141.34) show price near the middle of the range, indicating no significant extension in either direction.
Volume
Below average. Latest daily volume of 3,421,500 is 78.3% of the 20-period average (4,371,000), indicating reduced participation during the consolidation phase.

Assessment

The daily timeframe shows a neutral-to-cautious picture. Price is consolidating in a range between the SMA20 and SMA50, with the short-term moving averages in bearish alignment. The RSI just below 50 and the negative MACD histogram point to a lack of near-term buying conviction. A break above the SMA50 at 135.10 would be the first positive signal for the daily trend.

Weekly (July 6, 2026 week)

Trend
Bullish. Price at 133.89 is above SMA20 (130.20), SMA50 (119.45), and SMA200 (92.18). All weekly SMAs remain in a bullish ascending order (SMA20 > SMA50 > SMA200), confirming the long-term uptrend is intact despite the recent weekly pullback from the 148.52 high.
Momentum
Neutral with improving bias. RSI14 at 52.41 has pulled back from overbought levels above 70 in previous months and is now near the midline. This is a healthy consolidation of momentum rather than a bearish signal. MACD at 2.15 is above the zero line but below the signal line at 2.68, with a negative histogram at -0.53, reflecting the ongoing weekly correction.
Volatility
Moderate. ATR14 at 6.95 (5.19% of price) reflects typical weekly ranges for a large-cap pharmaceutical. Bollinger Bands (109.53 to 152.31) are reasonably wide, with price in the lower half of the band range.
Volume
Slightly below average. Weekly volume of 17,895,400 is 85.1% of the 20-week average (21,024,500).

Assessment

The weekly timeframe confirms a healthy long-term uptrend with all key SMAs in bullish alignment. The RSI at 52.41 has reset from overbought territory to neutral, setting up a potential re-entry point for the trend. The price correction from 148.52 to current levels appears orderly, with the SMA20 at 130.20 acting as near-term support. The weekly trend remains bullish as long as price holds above the SMA50 at 119.45.

Key indicators

NVS Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)48.3252.41
MACD (12, 26, 9)-0.85 / -0.53 / -0.322.15 / 2.68 / -0.53
ATR (14)4.18 (3.10%)6.95 (5.19%)
Bollinger Bands (20, 2)123.72 - 141.34109.53 - 152.31
SMA (20)131.55130.20
SMA (50)135.10119.45
SMA (200)121.3092.18

Price structure

NVS Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price134.72133.89
1-Period Return+1.03%+1.45%
5-Period Return-0.88%-4.12%
20-Period Return-8.10%+2.83%
60-Period Return+6.91%+14.70%
252-Period Return+10.50%+45.20%
52-Week Low82.4082.40
52-Week High148.52148.52
52-Week Position68.12%66.85%

Key levels

NVS Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High140.13148.52
20-Period Low128.52126.35
60-Period High148.52148.52
60-Period Low112.45105.30

Scenarios

NVS Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

Price breaks above SMA50 resistance at 135.10 with above-average volume, followed by a move toward the 20-day high at 140.13 and eventually the 52-week high at 148.52.

Invalidation

Price falls below the 20-day low of 128.52.

What to watch

Daily RSI reclaiming the 50 midline and continuing higher; MACD histogram turning positive.

Range-Bound

Trigger

Price oscillates between SMA20 support at 131.55 and SMA50 resistance at 135.10, with the MACD staying near the zero line.

Invalidation

A decisive break of either boundary with above-average volume.

What to watch

RSI staying between 40 and 55; declining volume suggesting consolidation rather than distribution.

Bearish

Trigger

Price breaks below 128.52 (20-day low) and fails to hold SMA20, opening the path toward the 200-day SMA at 121.30.

Invalidation

Price reclaims the SMA50 at 135.10 and holds above it.

What to watch

Sustained closes below SMA20 (131.55); weekly MACD histogram turning more negative.

Methodology

Methodology and Limitations

This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Google Finance (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 14, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 6, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 14, 2026, weekly July 6, 2026 week. Generated July 15, 2026.